SMAD4 and cancer: Monoubiquitylation also regulates the SMAD4-mediated signaling, and it is worth mentioning that SCFskp2 E3 ligase ubiquitylates SMAD4 at the MH2 domain [109], enabling SMAD4 mutations in cancer to be degraded.